NKTR - NEKTAR THERAPEUTICS
93.2
-4.960 -5.322%
Share volume: 3,621,557
Last Updated: 04-22-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.18%
PREVIOUS CLOSE
CHG
CHG%
$98.16
-4.96
-0.05%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-07-2024 | 03-14-2025 | 05-08-2025 | 08-07-2025 | 11-06-2025 | 03-12-2026 | |
| Assets | |||||||||
| Total Assets | 396.012 M | 343.334 M | 307.966 M | 303.850 M | 256.241 M | 207.534 M | 301.347 M | 280.406 M | |
| Current Assets | 319.836 M | 295.188 M | 286.481 M | 261.292 M | 229.913 M | 186.566 M | 281.357 M | 266.266 M | |
| Inventories | 16.238 M | 14.465 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 10.743 M | 8.292 M | 8.933 M | 6.066 M | 11.281 M | 10.663 M | 11.149 M | 20.514 M | |
| Short Term Investments | 240.596 M | 243.295 M | 214.386 M | 210.974 M | 179.738 M | 132.915 M | 229.176 M | 230.636 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 48.642 M | 27.940 M | 30.109 M | 44.252 M | 38.894 M | 42.988 M | 41.032 M | 15.116 M | |
| Total Non-current Assets | 36.778 M | 19.405 M | 4.537 M | 26.087 M | 9.776 M | 5.371 M | 4.837 M | 3.491 M | |
| Property Plant Equipment | 17.475 M | 15.187 M | 3.603 M | 3.411 M | 3.162 M | 2.988 M | 2.826 M | 2.060 M | |
| Other Assets | 58.701 M | 32.959 M | 17.882 M | 39.147 M | 23.166 M | 17.980 M | 17.164 M | 12.080 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 396.012 M | 343.334 M | 307.966 M | 303.850 M | 256.241 M | 207.534 M | 301.347 M | 280.406 M | |
| Total liabilities | 269.307 M | 263.646 M | 259.082 M | 243.113 M | 242.503 M | 231.745 M | 216.261 M | 190.574 M | |
| Total current liabilities | 52.406 M | 57.326 M | 67.583 M | 61.400 M | 70.930 M | 71.391 M | 66.340 M | 53.536 M | |
| Accounts Payable | 8.757 M | 6.475 M | 8.577 M | 11.560 M | 17.834 M | 14.281 M | 15.563 M | 10.770 M | |
| Other liabilities | 216.901 M | 206.320 M | 191.499 M | 181.713 M | 171.573 M | 160.354 M | 149.921 M | 137.038 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 216.901 M | 206.320 M | 191.499 M | 181.713 M | 171.573 M | 160.354 M | 149.921 M | 137.038 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 126.705 M | 79.688 M | 48.884 M | 60.737 M | 13.738 M | -24.211 M | 85.086 M | 89.832 M | |
| Common stock | 3.644 B | 3.650 B | 3.655 B | 3.660 B | 3.664 B | 3.667 B | 3.809 B | 3.850 B | |
| Retained earnings | -3.514 B | -3.566 B | -3.603 B | -3.596 B | -3.647 B | -3.689 B | -3.724 B | -3.760 B |